FACTORS ASSOCIATED WITH PERSISTENCE OF HPV GENITAL INFECTION IN A SMALL COHORT OF ROMANIAN WOMEN.
Adult
Cohort Studies
Female
Genital Diseases, Female
/ diagnosis
Humans
Male
Middle Aged
Papillomaviridae
/ isolation & purification
Papillomavirus Infections
/ diagnosis
Prevalence
Risk Factors
Romania
/ epidemiology
Sexual Behavior
Sexual Partners
Sexually Transmitted Diseases
/ diagnosis
Smoking
/ epidemiology
Papillomavirus infections
Romania
Sexual behavior
Surveys and questionnaires
Journal
Acta clinica Croatica
ISSN: 1333-9451
Titre abrégé: Acta Clin Croat
Pays: Croatia
ID NLM: 9425483
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
entrez:
24
1
2020
pubmed:
24
1
2020
medline:
18
4
2020
Statut:
ppublish
Résumé
The aim of the study was to assess the role of behavioral factors in persistence of human papillomavirus (HPV) genital infection. Out of a cohort of 605 women included in a study of HPV infection prevalence, 142 HPV positive women (aged 18-57) were retested after a 12-month interval. None of the patients underwent surgical treatment during that period. Selected patients were asked for a second smear for cytologic analysis and HPV genotyping. A questionnaire that included information regarding reproductive health, sexual activity and smoking status was filled-in. After 12 months, 46 of 142 (32.39%) women had persistent HPV infection, with genotypes 16 and 18 found in 27 cases. On the other hand, 17 of 142 (11.97%) women had acquired new infections replacing the baseline genotypes. In our study, smoking (OR=2.320, p=0.0330) and sexual behavior (OR=5.333, p=0.0180 for more than three sexual partners; OR=2.427, p=0.0238 for cases where the partner was involved in another sexual relationship) were associated with viral persistence, while long-term contraception did not yield statistically significant results.
Identifiants
pubmed: 31969751
doi: 10.20471/acc.2019.58.03.02
pii: acc-58-410
pmc: PMC6971790
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
410-416Références
APMIS. 2011 Jan;119(1):1-9
pubmed: 21143521
J Med Virol. 2008 Aug;80(8):1434-40
pubmed: 18551620
J Natl Cancer Inst Monogr. 2003;(31):20-8
pubmed: 12807941
Acta Clin Croat. 2017 Sep;56(3):369-374
pubmed: 29479901
Arch Pathol Lab Med. 2003 Aug;127(8):930-4
pubmed: 12873163
Nat Rev Immunol. 2002 May;2(5):372-7
pubmed: 12033743
Nat Rev Cancer. 2007 Jan;7(1):11-22
pubmed: 17186016
J Natl Cancer Inst. 2009 Jan 21;101(2):88-99
pubmed: 19141778
Gynecol Obstet Fertil. 2008 Apr;36(4):430-40
pubmed: 18417407
Int J Cancer. 2016 Jan 15;138(2):361-8
pubmed: 26238558
J Natl Cancer Inst. 2011 Mar 2;103(5):368-83
pubmed: 21282563
Gynecol Oncol. 2007 Nov;107(2 Suppl 1):S2-5
pubmed: 17938014
J Natl Cancer Inst. 2002 Nov 6;94(21):1604-13
pubmed: 12419786
Eur J Gynaecol Oncol. 2005;26(5):491-8
pubmed: 16285563
CMAJ. 2001 Apr 3;164(7):1017-25
pubmed: 11314432
J Natl Compr Canc Netw. 2008 Jan;6(1):83-95
pubmed: 18267061
N Engl J Med. 1998 Feb 12;338(7):423-8
pubmed: 9459645
Am J Obstet Gynecol. 2000 Feb;182(2):257-64
pubmed: 10694321
Vaccine. 2008 Aug 19;26 Suppl 10:K1-16
pubmed: 18847553
N Engl J Med. 2003 Feb 6;348(6):518-27
pubmed: 12571259
J Pathol. 2006 Jan;208(2):152-64
pubmed: 16362994
Clin Microbiol Rev. 2003 Jan;16(1):1-17
pubmed: 12525422
Gynecol Oncol. 2003 Aug;90(2):358-65
pubmed: 12893200
Arch Virol. 2014 Dec;159(12):3305-20
pubmed: 25143263